Drugs / APLA12
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01123655 | Oct 2009 → Sep 2015 | rheumatoid arthritis | VA Office of Research and Development | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | APL A12 | “orally administered APL A12 at one or more doses” NCT01123655 ↗ |
| Route | Oral | “orally administered APL A12” NCT01123655 ↗ |